title: Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir.
authors.affiliation: aUnit of Infectious Diseases, A. Manzoni Hospital, Lecco bUnit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Sassari, Sassari cUnit of Infectious Diseases, San Matteo Hospital, Pavia dInfectious Diseases Clinic, Department of Internal Medicine, San Gerardo Hospital, University of Milano-Bicocca, Monza eDepartment of Infectious Diseases, Amedeo di Savoia Hospital, Turin fUnit of Infectious Diseases, ASST Valle Olona, Busto Arsizio gInfectious Diseases Unit, DIBIC 'Luigi Sacco', University of Milan, Milan hUnit of Infectious Diseases, Garibaldi Hospital, Catania iUnit of Infectious Diseases, University of Bari, Bari jDepartment of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milan, Italy.
authors.forename: Paolo
authors.initials: P
authors.lastname: Bonfanti
authors.forename: Giordano
authors.initials: G
authors.lastname: Madeddu
authors.forename: Roberto
authors.initials: R
authors.lastname: Gulminetti
authors.forename: Nicola
authors.initials: N
authors.lastname: Squillace
authors.forename: Giancarlo
authors.initials: G
authors.lastname: Orofino
authors.forename: Paola
authors.initials: P
authors.lastname: Vitiello
authors.forename: Stefano
authors.initials: S
authors.lastname: Rusconi
authors.forename: Benedetto M
authors.initials: BM
authors.lastname: Celesia
authors.forename: Paolo
authors.initials: P
authors.lastname: Maggi
authors.forename: Elena
authors.initials: E
authors.lastname: Ricci
mesh_terms: D015331:Cohort Studies; D015658:HIV Infections; D019428:HIV Integrase Inhibitors; D006575:Heterocyclic Compounds, 3-Ring; D006801:Humans; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D000099226:Dolutegravir
chemical_list: D019428:HIV Integrase Inhibitors; D006575:Heterocyclic Compounds, 3-Ring; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D000099226:Dolutegravir